References
- Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classi-fication based on endothelial characteristics. Plast Reconst Surg. 1982;69:412–420.
- Enjolras 0, Riche MC, Merlandjj, Escande JP. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics. 1990;85: 491–498.
- Frieden IJ, EichenfieldLF, Esterly NB, Geronemus R, Mallory SB. Guidelines of c are for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Co mmittee.J Am Acad Dermato/. 1997;37:631–637.
- Wahrman JE, Honig PJ. Hemangiomas. Pediatr Rev. 1994;15 (7):266–271.
- Ozsoylu S, Irken G, Gargey A. High dose intravenous methylprednisolone for Kasabach—Merritt syndrome. Eur. J Pediatr. 1989;148:403–405.
- Ozsoylu S. Megadose methylprednisolone for Kasabach—Merritt syndrome. AmJPediatr Hematol Oncol. 1993;10:197–198.
- Sadan N, Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr. 1996;128:141–146.
- Frieden IJ. Which hemangiomas to treat—and how? Arch Dermatol 1997;133:1593–1595.
- Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N EnglJ Med. 1999;341:173–181.
- Ozsoylu 5, Ertark G. Oral megadose methylprednisolone for childhood acute idiopathic thrombo-cytopenic purpura (ITP). Blood. 1991;77:1856–1857.
- Boon LM, MacDonald DM, Mulliken RN, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconst Surg. 1999;104:1616–1623.
- Sherrington CA, Sim DKY, Freezer NJ, Robertson CF. Subglottic haemangioma. Arch Dis Child. 1997;76:458–459.
- Ozsoylu 5. High dose intravenous methylprednisolone (HIVMP) in hematologic disorder. Hematol Rev. 4:197–207.